Treatment efficacy of Ampicillin/Sulbactam in comparison to alternative beta-lactams for severe Acinetobacter baumannii infections

Kirsten BuseyDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA;

Jason FerreiraDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA;

Petra AldridgeCenter for Health Equity and Quality Research, University of Florida Health Jacksonville, Jacksonville, FL, USA;

Donald JohnsonDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA;

Nilmarie GuzmanDepartment of Medicine, Division of Infectious Disease, University of Florida Health Jacksonville, Jacksonville, FL, USA

Christopher A. JankowskiDepartment of Pharmacy, University of Florida Health Jacksonville, Jacksonville, FL, USA; Correspondence[email protected]

Click to increase image sizeClick to decrease image size

Disclosure statement

The authors of this paper have no conflicts of interest to report.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Treatment efficacy of Ampicillin/Sulbactam in comparison to alternative beta-lactams for severe Acinetobacter baumannii infections

Disclosure statement

Information for

Open access

Opportunities

Help and information

Treatment efficacy of Ampicillin/Sulbactam in comparison to alternative beta-lactams for severe Acinetobacter baumannii infections

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature